Check Cap Ltd (CHEK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Check Cap Ltd (CHEK) has a cash flow conversion efficiency ratio of 0.000x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-536.00) by net assets ($-1.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review financial agility of Check Cap Ltd to assess the company's free cash flow relative to its total liabilities.
Check Cap Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Check Cap Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see CHEK stock market capitalisation for the company's overall valuation and market capitalisation.
Check Cap Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Check Cap Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LABORATORIO FARMAC.ERFO
F:RK7
|
N/A |
|
ECSTELECOM Co. Ltd
KQ:067010
|
0.056x |
|
Manho Rope&Wir
KO:001080
|
-0.009x |
|
ITM Power
LSE:ITM
|
-0.009x |
|
TSR Capital Bhd
KLSE:5042
|
0.016x |
|
Weha Transportasi Indonesia TBK
JK:WEHA
|
0.069x |
|
Arb Bhd
KLSE:7181
|
-0.082x |
|
UV Germi SA
PA:ALUVI
|
0.031x |
Annual Cash Flow Conversion Efficiency for Check Cap Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Check Cap Ltd from 2012 to 2025. View CHEK live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-1.45 Million | $-8.00K | 0.006x | -99.90% |
| 2024-12-31 | $-1.45 Million | $-8.00 Million | 5.520x | +871.22% |
| 2023-12-31 | $23.69 Million | $-16.95 Million | -0.716x | -58.06% |
| 2022-12-31 | $41.31 Million | $-18.71 Million | -0.453x | -41.13% |
| 2021-12-31 | $50.69 Million | $-16.26 Million | -0.321x | +59.93% |
| 2020-12-31 | $16.38 Million | $-13.11 Million | -0.801x | +61.14% |
| 2019-12-31 | $6.23 Million | $-12.84 Million | -2.060x | -167.53% |
| 2018-12-31 | $13.03 Million | $-10.03 Million | -0.770x | +50.30% |
| 2017-12-31 | $5.91 Million | $-9.15 Million | -1.550x | -103.53% |
| 2016-12-31 | $10.41 Million | $-7.92 Million | -0.761x | -11.60% |
| 2015-12-31 | $12.65 Million | $-8.63 Million | -0.682x | +66.55% |
| 2014-12-31 | $2.23 Million | $-4.54 Million | -2.039x | +33.59% |
| 2013-12-31 | $1.19 Million | $-3.66 Million | -3.071x | -278.58% |
| 2012-12-31 | $5.13 Million | $-4.16 Million | -0.811x | -- |
About Check Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.